Artemis Medicare Services Limited
ARTEMISMED.NS
National Stock Exchange of India275.90
INR
+16.05
- -
Artemis Medicare Services Limited
ARTEMISMED.NS
(National Stock Exchange of India)
Recent
price
275.90
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Artemis Medicare Services Limited is engaged in healthcare services, primarily operating multi-specialty tertiary care hospitals under the brand Artemis Hospitals. The company offers a comprehensive range of advanced medical and surgical services including cardiology, oncology, orthopedics, neurology, nephrology, gastroenterology, critical care, radiology, ophthalmology, urology, dental care, and pain management. Artemis Hospitals also provides ancillary services such as billing and insurance, childcare, emotional and support programs, full body checkup, international patient services, medical interpretation, and medical record management. The company operates a 448-bedded multi-specialty hospital in Gurgaon, Haryana, and has expanded its reach through smaller multi-specialty centers focused on maternal and newborn care, branded as Daffodils, with 30 to 40 beds each. Additionally, Artemis Medicare Services Limited has extended its operations overseas by entering into hospital operation and maintenance contracts in Mauritius. Founded in 2004 and headquartered in Gurgaon, Haryana, Artemis Medicare Services is a sister concern of the Apollo Tyres Group. The company targets patient segments requiring advanced tertiary and specialty healthcare services in India and select overseas markets. Artemis Hospitals is known for integrating state-of-the-art medical technologies such as the M6 CyberKnife system for radiation therapy and the da Vinci Robotic Surgical system, focusing on innovation in treatment. Recent strategic developments include a significant investment of INR 330 crore (approximately $40 million) in 2024 from the International Finance Corporation (IFC), part of the World Bank Group, through Compulsorily Convertible Debentures (CCDs). This funding supports Artemis Medicare's expansion plans by increasing bed capacity, introducing new medical specialties, and establishing cardiac care centers in Tier 2 and Tier 3 cities across India. The company has utilized part of these funds to enter a binding memorandum of understanding with Dr. Vidya Sagar Kaushalya Devi Memorial Health Centre for exclusive rights, indicating strategic partnerships to enhance regional healthcare presence. IFC converted CCDs, raising their equity stake to approximately 12% by late 2025. Artemis Medicare Services Ltd continually pursues growth through both brownfield and greenfield expansion opportunities, with a focus on improving healthcare accessibility and quality. The company maintains operational excellence and quality standards evidenced by accreditations such as the National Accreditation Board for Hospitals and Healthcare Providers (NABH) and the Joint Commission International (JCI). In summary, Artemis Medicare Services Limited is a leading healthcare provider in India offering comprehensive multi-specialty hospital services, backed by advanced technologies and strategic partnerships, with ongoing expansions supported by international funding and operational contracts in select overseas markets.